Achira
7 known investors
Achira builds molecular world models that blend geometric deep learning, physics, and quantum chemistry to advance drug discovery and materials design. The company combines AI and physical simulation to enable out-of-sample prediction for biomolecular applications.
Founders & leadership
JC
John ChoderainPresident / CEO
TK
Theofanis Karaletsos
Board
ZD
Investors · 7
Compound✓ verifiedNew York · $400K – $1.5M
NVIDIA✓ verifiedSanta Clara
Amplify PartnersMenlo Park · $500K – $5M
DIMENSIONreportedTokyo
Dimension CapitalreportedSan Francisco · $1M – $10M
NVenturesreportedSingapore · $25K – $2.5M
Also in the syndicate · 1
Amplify
Funding
SEC filings, press & company announcements$33M disclosed across 1 of 3 rounds · 2025
- Undisclosed amountseed roundApr 2025
Amplify, Compound, Dimension, Nvidia
Source ↗ - $33MraisedFeb 2025 · 2 sourcesSource ↗
- Undisclosed amountseed roundFeb 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlap
Xaira Therapeutics6 shared keywordsXaira develops AI and machine learning tools for drug discovery and protein design, serving pharmaceutical and biotech companies.
Aiera4 shared keywordsAiera provides AI-enabled infrastructure that gives institutional research teams permissioned, entitlement-aware access to proprietary financial content such as broker research, expert insights, transcripts, filings, live earnings calls, and news through a single searchable environment. It is built for regulated financial environments, offering governance, transparent attribution, auditability, and integrations via enterprise APIs and MCP for AI workflows.
Companies competing with Achira for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Achira do?
- Achira builds molecular world models that blend geometric deep learning, physics, and quantum chemistry to advance drug discovery and materials design. The company combines AI and physical simulation to enable out-of-sample prediction for biomolecular applications.
- Who founded Achira?
- Achira was founded by John Chodera, Theofanis Karaletsos.
- Who are Achira's investors?
- Achira's investors include Compound, NVIDIA, Amplify Partners, DIMENSION, Dimension Capital, NVentures.
- How much funding has Achira raised?
- Achira has disclosed $33M raised across 1 of its 3 known rounds.